Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of GKT137831 in Patients With Idiopathic Pulmonary Fibrosis
NCT03865927 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of GKT137831 in Patients With Idiopathic Pulmonary Fibrosis
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 7, 2020
- Completion date
- November 30, 2024
- Enrollment
- 58 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.